The GlaxoSmithKline and Merck Group-backed digital fertility platform has raised $14.7m, a year after it was formed by the merger of Auxogyn and Fertility Authority.

Hewlett Packard Enterprise has invested as part of the cloud analytics platform's $14.7m series B, participating through its Hewlett Packard Pathfinder division.

Immuno-oncology therapy developer Intensity Therapeutics has added a $10m SalvaRx-backed round to $2.25m of earlier financing.

Novel's investment subsidiary Novel TMT Ventures has returned to back an $11.4m series A round for mobile-first e-commerce platform PredictSpring.

Cybersecurity startup Verodin has closed a series A round backed by Cisco Investments, two months after it came out of stealth.

The Chinese business media company. a spinout of People's Daily, has secured series B capital in a round featuring Xiaomi and Cheetah Mobile.

Deep learning technology developer Netradyne has secured series A funding from Reliance Industries to help bring its products to market.

Pharmaceutical company CoSci Med-Tech led the round, which will help JDP Therapeutics advance a treatment for allergic reactions in hospitals through phase 3 trials.

Logistics service GlobalTranz has spun out its freight tracking technology developer 10-4 Systems, with GlobalTranz co-founder Andrew Leto leading its series A round.

Imperial Innovations has contributed to a series A round for small-molecule oncology treatment developer Storm Therapeutics, a Cambridge spinout.